Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
  1. Home
  2. Stock
  3. INGR
INGR logo

INGR Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Ingredion Inc (INGR) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
111.150
1 Day change
-1.27%
52 Week Range
141.780
Analysis Updated At
2026/03/06
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.
Sign Up

Ingredion Inc (INGR) is not a strong buy for a beginner, long-term investor at this moment. While the company has shown positive net income and EPS growth in the latest quarter, the technical indicators are bearish, insider selling is significant, and the CEO's recent share sale raises concerns about future performance. Additionally, the options data and analyst ratings do not indicate strong bullish sentiment. Given the user's preference for long-term investment and the current market conditions, it is better to hold off on investing in this stock for now.

Technical Analysis

The technical indicators for INGR are bearish. The MACD is negative and expanding downward, the RSI is neutral but leaning towards oversold territory, and the moving averages indicate a bearish trend (SMA_200 > SMA_20 > SMA_5). The stock is trading below key pivot levels, with support at 113.297 and resistance at 117.986.

Options Data

Bullish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
11
Buy
3

Positive Catalysts

  • Hedge funds have significantly increased their buying activity, up 137.50% over the last quarter. The company's net income and EPS have shown strong YoY growth in the latest quarter.

Neutral/Negative Catalysts

  • Insiders, including the CEO, have been selling shares significantly, with insider selling increasing by over 9 million percent in the last month. The CEO's sale of 23.2% of his holdings has raised concerns about the company's future performance. The company's Q4 revenue and gross margin have declined YoY, and the Texture & Healthful Solutions segment has shown weaker profits.

Financial Performance

In Q4 2025, Ingredion's revenue dropped by 2.39% YoY to $1.757 billion. However, net income increased by 73.68% YoY to $165 million, and EPS rose by 79.72% YoY to 2.57. Gross margin declined slightly by 1.88% YoY to 24.47%.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Analysts have mixed views on INGR. UBS raised the price target to $124 but maintained a Neutral rating. BMO Capital lowered the price target to $120 and maintained a Market Perform rating, citing weaker profits in certain segments. Barclays raised the price target to $128 but highlighted headwinds from a facility outage.

Wall Street analysts forecast INGR stock price to rise
4 Analyst Rating
Wall Street analysts forecast INGR stock price to rise
1 Buy
3 Hold
0 Sell
Hold
Current: 112.580
sliders
Low
119
Averages
125.5
High
136
Current: 112.580
sliders
Low
119
Averages
125.5
High
136
UBS
Neutral
maintain
$119 -> $124
AI Analysis
2026-02-05
Reason
UBS
Price Target
$119 -> $124
AI Analysis
2026-02-05
maintain
Neutral
Reason
UBS raised the firm's price target on Ingredion to $124 from $119 and keeps a Neutral rating on the shares.
BMO Capital
Andrew Strelzik
Market Perform
downgrade
$123 -> $120
2026-02-04
Reason
BMO Capital
Andrew Strelzik
Price Target
$123 -> $120
2026-02-04
downgrade
Market Perform
Reason
BMO Capital analyst Andrew Strelzik lowered the firm's price target on Ingredion to $120 from $123 and keeps a Market Perform rating on the shares. The firm's Q4 results missed consensus estimates, reflecting weaker profits in Texture & Healthful Solutions segment, the analyst tells investors in a research note.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for INGR
Unlock Now

People Also Watch